Janus Henderson Group PLC Amicus Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,753,710 shares of FOLD stock, worth $24.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,753,710
              Previous 3,321,153
              
        
           17.09%
        
      
          
        Holding current value
$24.5 Million
            Previous $27.1 Million
            
        
           41.78%
        
      
          
        % of portfolio
0.01%
            Previous 0.02%
          
        Shares
	  33 transactions
	
  Others Institutions Holding FOLD
# of Institutions
304Shares Held
332MCall Options Held
396KPut Options Held
249K- 
    
      Vanguard Group Inc Valley Forge, PA29.4MShares$262 Million0.0% of portfolio
- 
    
      Wellington Management Group LLP Boston, MA29.1MShares$259 Million0.03% of portfolio
- 
    
      Black Rock Inc. New York, NY24.4MShares$217 Million0.01% of portfolio
- 
    
      Avoro Capital Advisors LLC New York, NY18MShares$160 Million1.88% of portfolio
- 
    
      William Blair Investment Management, LLC Chicago, IL14.6MShares$130 Million0.24% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $2.5B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...